Comera Life Sciences Holdings Balans Gezondheid
Financiële gezondheid criteriumcontroles 2/6
Comera Life Sciences Holdings has a total shareholder equity of $102.3K and total debt of $389.9K, which brings its debt-to-equity ratio to 381.2%. Its total assets and total liabilities are $3.1M and $3.0M respectively.
Belangrijke informatie
381.2%
Verhouding schuld/eigen vermogen
US$389.87k
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$1.77m |
| Aandelen | US$102.26k |
| Totaal verplichtingen | US$2.97m |
| Totaal activa | US$3.07m |
Recente financiële gezondheidsupdates
Recent updates
Comera Life Sciences rises on positive preclinical data from Sequrus study
Oct 18Comera life sciences expands woburn operations
Oct 04Comera Life Sciences announces up to $15M purchase agreement with Arena
Aug 31Comera Life Sciences GAAP EPS of -$1.14, revenue of $0.15M
Aug 10Comera Life Sciences Holdings (NASDAQ:CMRA) Is In A Good Position To Deliver On Growth Plans
May 27
Analyse van de financiële positie
Kortlopende schulden: CMRA's short term assets ($2.6M) do not cover its short term liabilities ($2.9M).
Langlopende schulden: CMRA's short term assets ($2.6M) exceed its long term liabilities ($37.3K).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: CMRA has more cash than its total debt.
Schuld verminderen: Insufficient data to determine if CMRA's debt to equity ratio has reduced over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: Insufficient data to determine if CMRA has enough cash runway based on its current free cash flow.
Voorspelling contante baan: Insufficient data to determine if CMRA has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.